283 research outputs found

    Francesco Comito, Piano

    No full text
    Chaconne in D Minor, for Violin Solo, BWV 1004, piano transcription / Johann Sabastian Bach, arr. Ferruccio Busoni; Pictures at an Exhibition / Modest Mussorgsky; Chorale Prelude for organ, in E-flat major, BWV 645, Wachet auf, ruft uns die Stimme ( Awake, calls the voice to us ), piano transcription; Chorale Prelude for organ in G minor, BWV 659, Nun komm\u27 der Heiden Heiland (Come now, Savior of the heathen ), piano transcription; Chorale Prelude for organ, in F minor, BWV 639, Ich ruf zu dir, Herr Jesu Christ (I call to you, Lord Jesus Christ ), piano transcription; Toccata and Fugue for organ in D minor, BWV 565, piano transcription / Johann Sebastian Bach, arr. Ferruccio Buson

    Francesco Comito, Piano

    No full text
    Chaconne in D Minor, for Violin Solo, BWV 1004, piano transcription / Johann Sabastian Bach, arr. Ferruccio Busoni; Pictures at an Exhibition / Modest Mussorgsky; Chorale Prelude for organ, in E-flat major, BWV 645, Wachet auf, ruft uns die Stimme ( Awake, calls the voice to us ), piano transcription; Chorale Prelude for organ in G minor, BWV 659, Nun komm\u27 der Heiden Heiland (Come now, Savior of the heathen ), piano transcription; Chorale Prelude for organ, in F minor, BWV 639, Ich ruf zu dir, Herr Jesu Christ (I call to you, Lord Jesus Christ ), piano transcription; Toccata and Fugue for organ in D minor, BWV 565, piano transcription / Johann Sebastian Bach, arr. Ferruccio Buson

    Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY

    No full text
    : With the recent regulatory approvals, the relatlimab-nivolumab combination brings new expectations and opens avenues toward effective immunotherapy combination in advanced melanoma. This work provides a critical insight into the recent phase II-III RELATIVITY-047 trial (NCT03470922), including a comparison with the CheckMate 067 trial on the current standard ipilimumab-nivolumab combination, with a focus on immune-related adverse events. Some imbalances of rare toxicities were noted, deserving careful monitoring and assessment in the upcoming real-world use. The promising efficacy data, although still early, should be carefully balanced against these toxicities, thus making pharmacovigilance and global patient-level data sharing crucial to identify the target population, promote safer prescribing and eventually clarify its place in therapy

    Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence

    No full text
    Two 64-year-old men were referred to our unit for the devel- opment of a cutaneous manifestation, during the 4th cycle of treatment with tebentafusp for liver metastases from uveal melanoma

    Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin–Goltz syndrome: A retrospective study

    No full text
    Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin–Goltz syndrome: A retrospective stud
    corecore